TGTX
TG THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$56.87
+0.71%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- $0.36
- Revenue estimate
- $247.1M
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.31
- Revenue actual
- $240.3M
- Revenue estimate
- $229.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -29.6%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $64
- PT range
- $20 – $86
- Analysts
- 4
3 Buy0 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | $0.31 | $0.05 | Miss -83.64% | $240.3M |
| May 6, 2026 | $0.23 | $0.17 | Miss -26.09% | $204.9M |
| Mar 3, 2025 | $0.08 | $0.15 | Beat 87.50% | $108.2M |
| May 1, 2024 | -$0.04 | -$0.07 | Miss -96.02% | $63.5M |
| Feb 28, 2024 | -$0.12 | -$0.09 | Beat 25.00% | $44.0M |
| Nov 1, 2023 | $0.12 | $0.73 | Beat 508.33% | $165.8M |
| Aug 1, 2023 | -$0.26 | -$0.34 | Miss -30.77% | $16.1M |
| May 1, 2023 | -$0.36 | -$0.28 | Beat 22.22% | $7.8M |
| Feb 28, 2023 | -$0.26 | -$0.39 | Miss -50.00% | $80.0K |
| Nov 10, 2022 | -$0.33 | -$0.26 | Beat 21.21% | $94.0K |
| Mar 1, 2022 | -$0.62 | -$0.70 | Miss -12.90% | $2.3M |
| Nov 4, 2021 | -$0.56 | -$0.65 | Miss -16.07% | $2.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026